PT Kalbe Farma Tbk. (PTKFY)
PT Kalbe Farma Tbk. Statistics
Share Statistics
PT Kalbe Farma Tbk. has 1.15M shares outstanding. The number of shares has increased by -12.18% in one year.
| Shares Outstanding | 1.15M |
| Shares Change (YoY) | -12.18% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | 0.27% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 0.12 and the forward PE ratio is null. PT Kalbe Farma Tbk.'s PEG ratio is 0.
| PE Ratio | 0.12 |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| Forward PS | n/a |
| PB Ratio | 0.02 |
| P/FCF Ratio | 0.11 |
| PEG Ratio | 0 |
Enterprise Valuation
PT Kalbe Farma Tbk. has an Enterprise Value (EV) of 72,869.7B.
| EV / Sales | 2.23 |
| EV / EBITDA | 15.79 |
| EV / EBIT | 0 |
| EV / FCF | 20.61 |
Financial Position
The company has a current ratio of 4.11, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.11 |
| Quick Ratio | 2.55 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.12 |
| Debt / FCF | 0.16 |
| Interest Coverage | 72.22 |
Financial Efficiency
Return on Equity is 14.22% and Return on Invested Capital is 12.23%.
| Return on Equity | 14.22% |
| Return on Assets | 11.01% |
| Return on Invested Capital | 12.23% |
| Revenue Per Employee | $2,528,696,900.57 |
| Profits Per Employee | $251,153,733.73 |
| Employee Count | 12,903 |
| Asset Turnover | 1.11 |
| Inventory Turnover | 3.03 |
Taxes
| Income Tax | 972.3B |
| Effective Tax Rate | 23.05% |
Stock Price Statistics
The stock price has increased by 8.1% in the last 52 weeks. The beta is 0.16, so PT Kalbe Farma Tbk.'s price volatility has been higher than the market average.
| Beta | 0.16 |
| 52-Week Price Change | 8.1% |
| 50-Day Moving Average | 14.45 |
| 200-Day Moving Average | 18.74 |
| Relative Strength Index (RSI) | 72.77 |
| Average Volume (20 Days) | 375 |
Income Statement
In the last 12 months, PT Kalbe Farma Tbk. had revenue of 32,627.8B and earned 3,240.6B in profits. Earnings per share was 2808800.
| Revenue | 32,627.8B |
| Gross Profit | 12,957B |
| Operating Income | 4,067.4B |
| Net Income | 3,240.6B |
| EBITDA | 4,614B |
| EBIT | 4,275.2B |
| Earnings Per Share (EPS) | 2808800 |
Balance Sheet
The company has 4,723.3B in cash and 559.22B in debt, giving a net cash position of 4,164.1B.
| Cash & Cash Equivalents | 4,723.3B |
| Total Debt | 559.22B |
| Net Cash | 4,164.1B |
| Retained Earnings | 22,941.8B |
| Total Assets | 29,429.7B |
| Working Capital | 13,001.9B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | -1,250.3B |
| Free Cash Flow | 3,534.8B |
| FCF Per Share | 15319.2 |
Margins
Gross margin is 39.71%, with operating and profit margins of 12.47% and 9.93%.
| Gross Margin | 39.71% |
| Operating Margin | 12.47% |
| Pretax Margin | 12.93% |
| Profit Margin | 9.93% |
| EBITDA Margin | 14.14% |
| EBIT Margin | 12.47% |
| FCF Margin | 10.83% |
Dividends & Yields
PTKFY pays an annual dividend of $0.39, which amounts to a dividend yield of 2.28%.
| Dividend Per Share | $0.39 |
| Dividend Yield | 2.28% |
| Dividend Growth (YoY) | -25.1% |
| Payout Ratio | 46.75% |
| Earnings Yield | 841.35% |
| FCF Yield | 4.59% |
Analyst Forecast
Currently there are no analyst rating for PTKFY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Oct 31, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Oct 31, 2012 |
| Split Type | forward |
| Split Ratio | 5:1 |
Scores
| Altman Z-Score | 3.21 |
| Piotroski F-Score | 8 |